Literature DB >> 2909685

Primary optic nerve sheath meningiomas. Report of nine cases.

W C Clark1, C S Theofilos, J C Fleming.   

Abstract

Between 1979 and 1987 the authors treated nine cases of primary optic nerve sheath meningioma. The definitive treatment for these lesions is surgical resection, although no single best plan for optimal management has been determined. The data indicate that only small anterior tumors may be removed with preservation of useful vision. With posterior circumferential tumors, there have been no cases of tumor removal with preservation of vision. A management strategy directed toward preservation of vision is discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2909685     DOI: 10.3171/jns.1989.70.1.0037

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

Review 1.  Detection and treatment of optic nerve sheath meningioma.

Authors:  Mark L Moster
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

2.  Primary and Secondary Optic Nerve Sheath Meningioma.

Authors:  Elena Solli; Roger E Turbin
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-18

3.  Surgical treatment of meningiomas of the orbit and optic canal: a retrospective study with particular attention to the visual outcome.

Authors:  L Cristante
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

4.  Fractionated stereotactic radiation therapy in the management of primary optic nerve sheath meningiomas.

Authors:  Stefanie Milker-Zabel; Peter Huber; Wolfgang Schlegel; Jürgen Debus; Angelika Zabel-du Bois
Journal:  J Neurooncol       Date:  2009-04-01       Impact factor: 4.130

5.  Prolonged vision return after radiosurgery for an optic nerve-sheath meningioma.

Authors:  Ali Kooshkabadi; Ismayilov Elchin; Hideyuki Kano; L Dade Lunsford
Journal:  J Radiosurg SBRT       Date:  2012

6.  Prior surgical intervention and tumor size impact clinical outcome after precision radiotherapy for the treatment of optic nerve sheath meningiomas (ONSM).

Authors:  Sebastian Adeberg; Thomas Welzel; Stefan Rieken; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2011-09-18       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.